نتایج جستجو برای: hexb

تعداد نتایج: 98  

2017
A Kolicheski G S Johnson N A Villani D P O'Brien T Mhlanga-Mutangadura D A Wenger K Mikoloski J S Eagleson J F Taylor R D Schnabel M L Katz

Consistent with a tentative diagnosis of neuronal ceroid lipofuscinosis (NCL), autofluorescent cytoplasmic storage bodies were found in neurons from the brains of 2 related Shiba Inu dogs with a young-adult onset, progressive neurodegenerative disease. Unexpectedly, no potentially causal NCL-related variants were identified in a whole-genome sequence generated with DNA from 1 of the affected do...

2016
Keisuke Kitakaze Chikako Tasaki Youichi Tajima Takatsugu Hirokawa Daisuke Tsuji Hitoshi Sakuraba Kohji Itoh

GM2 gangliosidoses are autosomal recessive lysosomal storage diseases (LSDs) caused by mutations in the HEXA, HEXB and GM2A genes, which encode the human lysosomal β-hexosaminidase (Hex) α- and β-subunits, and GM2 activator protein (GM2A), respectively. These diseases are associated with excessive accumulation of GM2 ganglioside (GM2) in the brains of patients with neurological symptoms. Here w...

Journal: :The Journal of clinical investigation 2009
Tomoya Terashima Kazuhiro Oka Angelika B Kritz Hideto Kojima Andrew H Baker Lawrence Chan

Dorsal root ganglion (DRG) neuron dysfunction occurs in a variety of sensory neuronopathies for which there are currently no satisfactory treatments. Here we describe the development of a strategy to target therapeutic genes to DRG neurons for the treatment of these disorders. We genetically modified an adenovirus (Ad) to generate a helper virus (HV) that was detargeted for native adenoviral tr...

2018
Maria L Allende Emily K Cook Bridget C Larman Adrienne Nugent Jacqueline M Brady Diane Golebiowski Miguel Sena-Esteves Cynthia J Tifft Richard L Proia

Sandhoff disease, one of the GM2 gangliosidoses, is a lysosomal storage disorder characterized by the absence of β-hexosaminidase A and B activity and the concomitant lysosomal accumulation of its substrate, GM2 ganglioside. It features catastrophic neurodegeneration and death in early childhood. How the lysosomal accumulation of ganglioside might affect the early development of the nervous sys...

2010
Seiichi Kanzaki Akira Yamaguchi Kayoko Yamaguchi Yoshitsugu Kojima Kyoko Suzuki Noriko Koumitsu Yoji Nagashima Kiyotaka Nagahama Michiko Ehara Yoshio Hirayasu Akihide Ryo Ichiro Aoki Shoji Yamanaka

BACKGROUND Sandhoff disease is a lysosomal storage disorder characterized by the absence of β-hexosaminidase and storage of GM2 ganglioside and related glycolipids. We have previously found that the progressive neurologic disease induced in Hexb(-/-) mice, an animal model for Sandhoff disease, is associated with the production of pathogenic anti-glycolipid autoantibodies. METHODOLOGY/PRINCIPA...

Journal: :Behavioural Brain Research SreeTestContent1 2016
Katie Richardson Achilleas Livieratos Richard Dumbill Steven Hughes Gauri Ang David A. Smith Lauren Morris Laurence A. Brown Stuart N. Peirson Frances M. Platt Kay E. Davies Peter L. Oliver

Sleep and circadian rhythm disruption is frequently associated with neurodegenerative disease, yet it is unclear how the specific pathology in these disorders leads to abnormal rest/activity profiles. To investigate whether the pathological features of lysosomal storage disorders (LSDs) influence the core molecular clock or the circadian behavioural abnormalities reported in some patients, we e...

Journal: :Human molecular genetics 2017
Alexander W M Hooper Javier F Alamilla Rosemarie E Venier Deda C Gillespie Suleiman A Igdoura

GM2 gangliosidoses are a group of lysosomal storage disorders which include Sandhoff disease and Tay-Sachs disease. Dysregulation of glutamate receptors has been recently postulated in the pathology of Sandhoff disease. Glutamate receptor association with neuronal pentraxins 1 and 2, and the neuronal pentraxin receptor facilitates receptor potentiation and synaptic shaping. In this study, we ha...

Journal: :The Journal of clinical investigation 1990
K Neote B McInnes D J Mahuran R A Gravel

Sandhoff disease is a recessively inherited lysosomal storage disease resulting from a deficiency of beta-hexosaminidase activity. The enzyme occurs in two major forms, beta-hexosaminidase A, composed of an alpha- and beta-subunit and beta-hexosaminidase B, composed of two beta-subunits. Both isozyme activities are deficient in Sandhoff disease, owing to mutations of the HEXB gene encoding the ...

Journal: :Science translational medicine 2016
Thomas Kirkegaard James Gray David A Priestman Kerri-Lee Wallom Jennifer Atkins Ole Dines Olsen Alexander Klein Svetlana Drndarski Nikolaj H T Petersen Linda Ingemann David A Smith Lauren Morris Claus Bornæs Signe Humle Jørgensen Ian Williams Anders Hinsby Christoph Arenz David Begley Marja Jäättelä Frances M Platt

Lysosomal storage diseases (LSDs) often manifest with severe systemic and central nervous system (CNS) symptoms. The existing treatment options are limited and have no or only modest efficacy against neurological manifestations of disease. We demonstrate that recombinant human heat shock protein 70 (HSP70) improves the binding of several sphingolipid-degrading enzymes to their essential cofacto...

2013
Yasuhiro Ogawa Makoto Tanaka Miho Tanabe Toshihiro Suzuki Tadayasu Togawa Tomoko Fukushige Takuro Kanekura Hitoshi Sakuraba Kazuhiko Oishi

Sandhoff disease (SD) is a glycosphingolipid storage disease that arises from mutations in the Hexb gene and the resultant deficiency in β-hexosaminidase activity. This deficiency results in aberrant lysosomal accumulation of the ganglioside GM2 and related glycolipids, and progressive deterioration of the central nervous system. Dysfunctional glycolipid storage causes severe neurodegeneration ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید